@article{11306,
  keywords = {Humans, *Aripiprazole/therapeutic use/adverse effects, Female, Male, Middle Aged, *Antipsychotic Agents/therapeutic use/adverse effects, Adult, *Mental Disorders/drug therapy, Quetiapine Fumarate/therapeutic use/adverse effects, Treatment Outcome, Risperidone/therapeutic use/adverse effects, Aged, Olanzapine/therapeutic use/adverse effects, Hospitalization/statistics & numerical data},
  author = {A. Richards-Belle and N. Launders and S. Hardoon and A. Richards and K. Man and N. Davies and E. Bramon and J. Hayes and D. Osborn},
  title = {Comparative cardiometabolic safety and effectiveness of aripiprazole in people with severe mental illness: A target trial emulation},
  year = {2025},
  journal = {PLoS Med},
  volume = {22},
  edition = {2025/01/23},
  number = {1},
  pages = {e1004520},
  isbn = {1549-1277 (Print)
1549-1277},
  doi = {10.1371/journal.pmed.1004520},
  note = {1549-1676
Richards-Belle, Alvin
Orcid: 0009-0006-3232-7069
Launders, Naomi
Orcid: 0000-0003-4241-938x
Hardoon, Sarah
Richards, Al
Man, Kenneth K C
Orcid: 0000-0001-8645-1942
Davies, Neil M
Orcid: 0000-0002-2460-0508
Bramon, Elvira
Hayes, Joseph F
Orcid: 0000-0003-2286-3862
Osborn, David P J
WT_/Wellcome Trust/United Kingdom
Comparative Study
Journal Article
Observational Study
United States
PLoS Med. 2025 Jan 23;22(1):e1004520. doi: 10.1371/journal.pmed.1004520. eCollection 2025 Jan.},
  language = {eng},
}